March 14, 2023 — The Society of Thoracic Surgeons (STS) has developed and launched a new risk calculator to estimate the ...
March 14, 2023 —MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo ...
March 13, 2023 — BioCardia, Inc., developer of cellular and cell-derived therapeutics for the treatment of ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 13, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...
March 13, 2023 — iRhythm Technologies, Inc., a leading digital health company focused on creating trusted solutions that ...
March 12, 2023 — As part of its ongoing news coverage of ACC23, the DAIC/dicardiology.com editorial team has condensed ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 10, 2023 — The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with ...
March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...
March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 9, 2023 — People with a recent diagnosis of atrial fibrillation (AF), the most common irregular heart rhythm, have ...
March 9, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...
March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...
March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...
March 8, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...